DMBT1 expression distinguishes anorectal from cutaneous melanoma

Histopathology

Volumn 54, Issue 2, 2009, Pages 233-240

  Helmke, Burkhard Maria ^a,d,e   Renner, Marcus ^b,d   Poustka, Annemarie ^b   Schirmacher, Peter ^a   Mollenhauer, Jan ^b,c   Kern, Michael André ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Elbe Kliniken   (Germany)

^e Klinikum Stade   (Germany)

Author keywords

Anal canal; Anorectal; DMBT1; Melanoma

Indexed keywords

DELETED IN MALIGNANT BRAIN TUMOR 1; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HMB45; PSORIASIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANORECTAL DISEASE; ANORECTAL MELANOMA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 58649088242     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03200.x     Document Type: Article

References (29)

1. Helmke BM, Otto HF. Anorectal melanoma. A rare and highly malignant tumor entity of the anal canal. Pathologe 2004 25 171 177.
2. Sutherland CM, Chmiel JS, Henson DE, Winchester DP. Patient characteristics, methods of diagnosis, and treatment of mucous membrane melanoma in the United States of America. J. Am. Coll. Surg. 1994 179 561 566.
3. Batsakis JG, Suarez P. Mucosal melanomas: a review. Adv. Anat. Pathol. 2000 7 167 180.
4. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on cancer and the American Cancer Society. Cancer 1998 83 1664 1678.
5. Miller BJ, Rutherford LF, McLeod GR, Cohen JR. Where the sun never shines: anorectal melanoma. Aust. NZ J. Surg. 1997 67 846 848.
6. Ben-Izhak O, Lichtig C. CEA reactivity in amelanotic malignant melanoma of the anal canal. Pathol. Res. Pract. 1993 189 1071 1076. Discussion 1077-1083.
7. Ben-Izhak O, Levy R, Weill S et al. Anorectal malignant melanoma. A clinicopathologic study, including immunohistochemistry and DNA flow cytometry. Cancer 1997 79 18 25.
8. Chute DJ, Cousar JB, Mills SE. Anorectal malignant melanoma: morphologic and immunohistochemical features. Am. J. Clin. Pathol. 2006 126 93 100.
9. Vijayaraghavan M, Kharbanda K, Mathur M. S-100 staining for the diagnosis of melanoma of the anal canal. Indian J. Pathol. Microbiol. 1992 35 113 117.
10. Davies H, Bignell GR, Cox C et al. Mutations of the BRAF gene in human cancer. Nature 2002 417 949 954.
11. Gorden A, Osman I, Gai W et al. Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Cancer Res. 2003 63 3955 3957.
12. Pollock PM, Harper UL, Hansen KS et al. High frequency of BRAF mutations in nevi. Nat. Genet. 2003 33 19 20.
13. Helmke BM, Mollenhauer J, Herold-Mende C et al. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology 2004 127 1815 1820.
14. Mollenhauer J, Wiemann S, Scheurlen W et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat. Genet. 1997 17 32 39.
15. Deichmann M, Mollenhauer J, Helmke B et al. Analysis of losses of heterozygosity of the candidate tumour suppressor gene DMBT1 in melanoma resection specimens. Oncology 2002 63 166 172.
16. Mollenhauer J, Deichmann M, Helmke B et al. Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer. Int. J. Cancer 2003 105 149 157.
17. Mollenhauer J, Herbertz S, Holmskov U et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res. 2000 60 1704 1710.
18. Clark WH Jr., From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 29 705 727.
19. Kerl H, Garbe C, Cerroni L, Wolff H. Histopathologie der Haut. Berlin : Springer Verlag, 2003 632 633.
20. Carlson JA, Slominski A, Linette GP et al. Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging. Am. J. Clin. Pathol. 2003 120 (Suppl. S101 S127.
21. Hillenbrand A, Barth TF, Henne-Bruns D, Formentini A. Anorectal amelanotic melanoma. Colorectal Dis. 2008 10 612 615.
22. Wu W, Kemp BL, Proctor ML et al. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res. 1999 59 1846 1851.
23. Takeshita H, Sato M, Shiwaku HO et al. Expression of the DMBT1 gene is frequently suppressed in human lung cancer. Jpn. J. Cancer Res. 1999 90 903 908.
24. Mori M, Shiraishi T, Tanaka S et al. Lack of DMBT1 expression in oesophageal, gastric and colon cancers. Br. J. Cancer 1999 79 211 213.
25. Sasaki K, Sato K, Akiyama Y, Yanagihara K, Oka M, Yamaguchi K. Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. Cancer Res. 2002 62 4894 4898.
26. Bikker FJ, van der Wal JE, Ligtenberg AJ et al. Salivary agglutinin/DMBT1SAG expression is up-regulated in the presence of salivary gland tumors. J. Dent. Res. 2004 83 567 571.
27. Hustinx SR, Cao D, Maitra A et al. Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression. Cancer Biol. Ther. 2004 3 1254 1261.
28. Mollenhauer J, Helmke B, Medina D et al. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis. Genes Chromosomes Cancer 2004 39 185 194.
29. Renner M, Bergmann G, Krebs I et al. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease. Gastroenterology 2007 133 1499 1509.